HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERSION IN WOMEN WITH GENITAL ULCERS

被引:81
|
作者
PLOURDE, PJ
PEPIN, J
AGOKI, E
RONALD, AR
OMBETTE, J
TYNDALL, M
CHEANG, M
NDINYAACHOLA, JO
DCOSTA, LJ
PLUMMER, FA
机构
[1] UNIV NAIROBI,DEPT MED MICROBIOL,WHO,CTR RES & TRAINING SEXUALLY TRANSMITTED DIS,NAIROBI,KENYA
[2] NAIROBI CITY COMMISS,SPECIAL TREATMENT CLIN,NAIROBI,KENYA
[3] UNIV MANITOBA,DEPT INTERNAL MED,WINNIPEG R3T 2N2,MB,CANADA
[4] UNIV MANITOBA,DEPT MED MICROBIOL,WINNIPEG R3T 2N2,MB,CANADA
来源
JOURNAL OF INFECTIOUS DISEASES | 1994年 / 170卷 / 02期
基金
英国医学研究理事会;
关键词
D O I
10.1093/infdis/170.2.313
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Genital ulcers are implicated as a risk factor enhancing susceptibility to human immunodeficiency virus type 1 (HIV-1) infection. A prospective study to determine the incidence of and risk factors associated with acquisition of HIV-1 in women with genital ulcers was done. HIV-1-seronegative women with genital ulcers attending a clinic for sexually transmitted diseases in Nairobi were followed to HIV-1 seroconversion over a 6-month period. Of 81 women, 10 seroconverted to HIV-1. The crude 6-month incidence of HIV-1 infection was 12%. Risk factors associated with seroconversion included cervical ectopy (rate ratio [RR], 4.9; 95% confidence interval [CI], 1.5-15.6) and pelvic inflammatory disease (RR, 6.3; 95% CI, 1.9-20.4). Thus, cervical ectopy and pelvic inflammatory disease may increase susceptibility to HIV-1 in women with genital ulcers.
引用
收藏
页码:313 / 317
页数:5
相关论文
共 50 条
  • [1] ACUTE MENINGORADICULITIS CONCOMITANT WITH SEROCONVERSION TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PATON, P
    POLY, H
    GONNAUD, PM
    TARDY, JC
    FONTANA, J
    KINDBEITER, K
    TETE, R
    MADJAR, JJ
    [J]. RESEARCH IN VIROLOGY, 1990, 141 (04): : 427 - 433
  • [2] MORPHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CHATTERJEE, S
    BASAK, S
    KHAN, NC
    [J]. PATHOBIOLOGY, 1992, 60 (04) : 181 - 186
  • [3] RADIOSENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONWAY, B
    TOMFORD, WW
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) : 978 - 979
  • [4] VARIANTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TOURNIER, JN
    VERRIER, B
    BIRON, FF
    MANDRAND, B
    PEYRAMOND, D
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (05): : 709 - 715
  • [5] INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PEDERSEN, C
    [J]. DANISH MEDICAL BULLETIN, 1994, 41 (01) : 12 - 22
  • [6] GYNECOLOGIC DISEASE IN WOMEN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    KORN, AP
    LANDERS, DV
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 9 (04): : 361 - 370
  • [7] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF THE BRAIN
    ATWOOD, WJ
    BERGER, JR
    KADERMAN, R
    TORNATORE, CS
    MAJOR, EO
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (04) : 339 - 366
  • [8] TRANSMISSION AND PATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONNOR, RI
    HO, DD
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 321 - 323
  • [9] INACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY ALCOHOLS
    VANBUEREN, J
    LARKIN, DP
    SIMPSON, RA
    [J]. JOURNAL OF HOSPITAL INFECTION, 1994, 28 (02) : 137 - 148
  • [10] CELLULAR LATENCY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    POMERANTZ, RJ
    BAGASRA, O
    BALTIMORE, D
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (04) : 475 - 480